Meta-analysis: Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes
20 Apr, 2019 | 16:07h | UTCCommentaries: Evidence Supporting Niacin Use for Cardiovascular Disease Prevention Evaluated – MPR (free) AND Niacin: Time to Revisit That FDA Indication – MedPage Today (free registration required)
Related Commentary on Twitter
Systematic review & meta-analysis shows #niacin may be useful in patients intolerant to #statins, but evidence may not be representative of current-day patients https://t.co/BIeGYYVbhw @PORTAL_Research @JAMACardio pic.twitter.com/LuHxTIalfe
— JAMA Network Open (@JAMANetworkOpen) April 16, 2019